County-Level Social Vulnerability is Associated With In-Hospital Death and Major Adverse Cardiovascular Events in Patients Hospitalized With COVID-19: An Analysis of the American Heart Association COVID-19 Cardiovascular Disease Registry

Abstract

Background: The COVID-19 pandemic has disproportionately affected low-income and racial/ethnic minority populations in the United States. However, it is unknown whether hospitalized patients with COVID-19 from socially vulnerable communities experience higher rates of death and/or major adverse cardiovascular events (MACEs). Thus, we evaluated the association between county-level social vulnerability and in-hospital mortality and MACE in a national cohort of hospitalized COVID-19 patients. Methods: Our study population included patients with COVID-19 in the American Heart Association COVID-19 Cardiovascular Disease Registry across 107 US hospitals between January 14, 2020 to November 30, 2020. The Social Vulnerability Index (SVI), a composite measure of community vulnerability developed by Centers for Disease Control and Prevention, was used to classify the county-level social vulnerability of patients’ place of residence. We fit a hierarchical logistic regression model with hospital-level random intercepts to evaluate the association of SVI with in-hospital mortality and MACE. Results: Among 16 939 hospitalized COVID-19 patients in the registry, 5065 (29.9%) resided in the most vulnerable communities (highest national quartile of SVI). Compared with those in the lowest quartile of SVI, patients in the highest quartile were younger (age 60.2 versus 62.3 years) and more likely to be Black adults (36.7% versus 12.2%) and Medicaid-insured (31.1% versus 23.0%). After adjustment for demographics (age, sex, race/ethnicity) and insurance status, the highest quartile of SVI (compared with the lowest) was associated with higher likelihood of in-hospital mortality (OR, 1.25 [1.03–1.53]; P =0.03) and MACE (OR, 1.26 [95% CI, 1.05–1.50]; P =0.01). These findings were not attenuated after accounting for clinical comorbidities and acuity of illness on admission. Conclusions: Patients hospitalized with COVID-19 residing in more socially vulnerable communities experienced higher rates of in-hospital mortality and MACE, independent of race, ethnicity, and several clinical factors. Clinical and health system strategies are needed to improve health outcomes for socially vulnerable patients.

Major adverse cardiovascular events are associated with necroptosis during severe COVID-19

“…Several epidemiological studies have extensively characterised MACE during and after COVID-19 [ 7 , 27 , 44 , 45 ]. A recent systematic review of 150 studies with 33,805 patients showed that COVID-19 increased the risk of developing MACE.…”

Moderating Effects of Racial Segregation on the Associations of Cardiovascular Outcomes with Walkability in Chicago Metropolitan Area

“…Fourth, the aggregation level is based on data availability, so there is a boundary issue. Fifth, the unequal distribution of health outcomes might be caused by unobserved sociodemographic and economic characteristics, such as social vulnerability and air quality since these features might affect health outcomes [ 65 , 66 , 67 ]. Future studies examining the associations between social and environmental characteristics and health outcomes are warranted.…”

Race-Based Differences in ST-Segment–Elevation Myocardial Infarction Process Metrics and Mortality From 2015 Through 2021: An Analysis of 178 062 Patients From the American Heart Association Get With The Guidelines–Coronary Artery Disease Registry

“…This method has been applied previously in registry analyses on cardiovascular disease. 19 In analyses separated by sex, the rates of achievement of the following 4 primary outcomes were compared among the 3 race and ethnic groups (with non-Hispanic White as the reference group): rate of prehospital ECG obtained among patients transported by EMS; arrival to ECG within 10 minutes if no prehospital ECG was obtained; arrival to PCI within 90 minutes; and FMC-to-PCI time within 90 minutes for EMStransported patients. Additional analyses compared by race and ethnic groups (again separately in women and men) were the achievement of 4 additional time-to-treatment STEMI metrics: ED length of stay ≤30 minutes; FMC-to-cardiac catheterization laboratory activation within 20 minutes; door-to-fibrinolysis within 30 minutes; and door-in to door-out time within 30 minutes.…”